Sector Update: Healthcare Shares Higher Pre-Market: Intercept Pharma Up 30%, Adding to Thursday's Big Gains
Healthcare shares are flat to higher in pre-market trade.
Shares of Intercept Pharma ( ICPT ) are back in the green this morning, rising nearly 30% pre-market after posting a whopping 280% rise in Thursday's regular session on the back of positive news on the company's liver drug.
ICPT hit a record high of $305 yesterday after the company said that its trial to study obeticholic acid (OCA) for the treatment of nonalcoholic steatohepatitis ( NASH ) has been stopped earlier than planned after already meeting the primary endpoint.
And, Immunomedics ( IMMU ) is 16% higher after it reported the first patient dosing in the company's Phase III registration study of its pancreatic cancer drug, yttrium-90 (90Y)-clivatuzumab tetraxetan.